PureTech Health Plc

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
AMGNAmgen, Inc. -0.15%285.511.5%$886.84m
MRNAModerna, Inc. 0.48%182.350.0%$766.05m
GILDGilead Sciences, Inc. 1.29%89.031.0%$711.02m
REGNRegeneron Pharmaceuticals, Inc. 0.68%766.392.6%$519.32m
VRTXVertex Pharmaceuticals, Inc. 0.19%321.371.9%$493.66m
BIIBBiogen, Inc. -0.98%298.901.8%$408.64m
ILMNIllumina, Inc. -0.95%218.763.2%$260.35m
BNTXBioNTech SE 0.16%169.740.0%$177.87m
BMRNBioMarin Pharmaceutical, Inc. 2.47%105.564.2%$171.26m
AXSMAxsome Therapeutics, Inc. 6.85%76.901.6%$154.62m
SNSSSunesis Pharmaceuticals, Inc. -5.78%2.120.7%$148.20m
MRTXMirati Therapeutics, Inc. 5.19%96.251.6%$147.31m
HALOHalozyme Therapeutics, Inc. 3.55%59.4418.4%$81.17m
NVAXNovavax, Inc. -1.96%16.5275.3%$77.50m
IMGOImago BioSciences, Inc. 0.03%35.730.0%$57.06m

Company Profile

PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company and Others. The Internal segment focuses on immunological, fibrotic, and lymphatic system mechanisms. The Controlled Founded Entities segment is composed of the group’s subsidiaries that are currently consolidated operational subsidiaries that either have or have plans to hire independent management teams and currently have already raised, or are currently in the process of raising, third-party dilutive capital. The Non-Controlled Founded Entities segment includes companies wherein the group no longer holds majority voting control as a shareholder and no longer has the right to elect a majority of the members of the subsidiaries’ Board of Directors. The Parent Company and Other segment represents activities that are not directly attributable to the operating segments, such as the activities of the parent, corporate support functions and certain research and development support functions that are not directly attributable to a strategic business segment as well as the elimination of intercompany transactions. The company was founded by Robert S. Langer Jr., Bennett M. Shapiro, and Daphne Zohar on May 8, 2015 and is headquartered in Boston, MA.